Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

March 27 2023 - Novartis' Kisqali cuts recurrence risk in early-stage breast cancer

Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novo's high-dose Rybelsus win tees up regulatory filings
BioNTech's COVID-19 vaccine revenue forecasts lower than expected
BrainStorm secures FDA adcomm for ALS therapy NurOwn
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings

Valeant and GlaxoSmithKline enter worldwide collaboration agreement for retigabine

RTT News

Thursday, August 28, 2008 - 11:11am

tags:

Merck's Charm Offensive

CNBC

Thursday, August 28, 2008 - 11:10am

tags:

BDSI gets good news on drug, though approval is delayed

Bizjournals.com

Thursday, August 28, 2008 - 10:54am

tags:

J&J to appeal Razadyne patent ruling

Marketwatch

Thursday, August 28, 2008 - 10:53am

tags:

Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE

Yahoo/AP

Thursday, August 28, 2008 - 9:21am

tags:

Report: Medicare Pays Too Much for Some New Generics

WSJ Online

Thursday, August 28, 2008 - 8:09am

tags:

Pfizer Is Worth Another Look

Seeking Alpha

Thursday, August 28, 2008 - 8:08am

tags:

Amgen to Stop Offering Discounts on Anemia Drug

New York Times, NY

Thursday, August 28, 2008 - 8:00am

tags:

CROs: The 'Big Pharma Effect'

Seeking Alpha

Thursday, August 28, 2008 - 7:58am

tags:

Amgen to discontinue discounts on anemia drug: report

Yahoo/Reuters

Thursday, August 28, 2008 - 6:33am

tags:

Boehringer Drugs Disappoint in Company-Sponsored Stroke Study

Bloomberg

Thursday, August 28, 2008 - 6:32am

tags:

UCB Cuts 2,000 Jobs to Spur Profit; Shares Decline

Bloomberg

Thursday, August 28, 2008 - 6:32am

tags:

Cell Genesys' Saving Grace

Forbes

Wednesday, August 27, 2008 - 10:30pm

tags:

Takeda's Velcade Found Better Than Standard Blood-Cancer Drug

Bloomberg

Wednesday, August 27, 2008 - 10:28pm

tags:

Efficacy Questions Still Dog Vytorin

Forbes

Wednesday, August 27, 2008 - 10:27pm

tags:

Rough Road Ahead For Byetta

Forbes

Wednesday, August 27, 2008 - 10:24pm

tags:

Vioxx settlement judge caps legal fees at 32 pct

Yahoo/AP

Wednesday, August 27, 2008 - 4:41pm

tags:

King Pharma a Hold, Pre-Acquisition

Yahoo/Zacks.com

Wednesday, August 27, 2008 - 4:26pm

tags:

Grim Reaper Hurts Cell Genesys

Forbes

Wednesday, August 27, 2008 - 4:25pm

tags:

Another Storm Brewing For Vytorin

Forbes

Wednesday, August 27, 2008 - 4:23pm

tags:

Pages

Latest CP Wire Articles

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Klick Health launches new healthcare venture studio

Medtech earnings reports: insights from major players' Q4 results

Key compliance issues for medtech firms transitioning to data-enabled solutions

Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

First-of-its-kind Whole Lung Simulator is Helping Michigan Researchers Predict New Treatments and Vaccines for TB – A Reemerging Global Health Threat

Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug

Korean firm LG Chem buying AVEO Oncology for $566M

Latest Pharmagather Articles

Behind the GoodRx-Express Scripts Partnership: How PBMs Profit from Discount Cards in Pharmacy Benefits (rerun)

Drug Channels

Winning the Race for Patient Access: Identifying Copay Accumulator Impact

Drug Channels

Gene Drives Are Coming

In the Pipeline

Organizing Our Thoughts About Cells - Finally

In the Pipeline

Drug Channels News Roundup, March 2023: My $0.02 on Insulin Price Cuts, AbbVie vs. AFPs, Optum Expands, ASAP340B, and Hooray for Pharmacists

Drug Channels

The Right Assay With the Right Cells

In the Pipeline

Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress

Drug Channels

Peptide-Encoded Screening Libraries

In the Pipeline

It's Not All Bad News: Data Shows There's a Collaborative Future for 340B

Drug Channels